A case of advanced hepatocellular carcinoma with lymph node metastasis with complete response after TS-1 therapy

DOI Web Site Web Site 6 Citations 18 References
  • Nakamura Kazuhisa
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Sato Yoshihisa
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Kawagoe Kei
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Okuyama Shuhei
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Matsuoka Hiroyasu
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Asaba Noriyuki
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Nezu Saeko
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Kawamura Naohiro
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Mori Hideaki
    The Third Department of Internal Medicine, Kyorin University School of Medicine
  • Takahashi Shin-ichi
    The Third Department of Internal Medicine, Kyorin University School of Medicine

Bibliographic Information

Other Title
  • ＴＳ－１投与にて著効が得られた縦隔リンパ節転移を伴った進行肝細胞癌の１例
  • 症例報告 TS-1投与にて著効が得られた縦隔リンパ節転移を伴った進行肝細胞癌の1例
  • ショウレイ ホウコク TS 1 トウヨ ニテ チョコウ ガ エラレタ ジュウカク リンパセツ テンイ オ トモナッタ シンコウ カン サイボウ ガン ノ 1レイ
  • A case of advanced hepatocellular carcinoma with lymph node metastasis with complete response after TS-1® therapy

Search this article

Abstract

A 64-year-old male with liver cirrhosis was diagnosed with hepatocellular carcinoma (HCC) of 1 cm in diameter in 2001. He was treated by percutaneous ethanol injection therapy (PEIT) four times and/or transcatheter arterial embolization (TAE) three times for recurrent HCC. Since mediastinal lymphnode metastasis was found in 2003, chemotherapy with UFT® was started. However UFT therapy could be continued only a half year because of pancytopenia, and because there was no change in either HCC or mediastinal lymphnode metastasis, PEIT and TAE continued. Due to the progression of HCC, chemotherapy with TS-1® was started in January 2005. After 6 months both HCC and mediastinal lymphnode metastasis disappeared and no recurrence has been found. It is probable that HCC and mediastinal lymphnode metastasis were sensitive to 5-FU, and the concentration of 5-FU was kept high by gimeracil (CDHP).<br>

Journal

  • Kanzo

    Kanzo 49 (5), 218-223, 2008

    The Japan Society of Hepatology

Citations (6)*help

See more

References(18)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top